本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cellectar Biosciences Inc.

1.39
-0.0400-2.80%
盘后:1.480.0869+6.25%19:58 EDT
成交量:53.93万
成交额:77.55万
市值:1,313.84万
市盈率:-0.63
高:1.60
开:1.55
低:1.36
收:1.43
52周最高:5.07
52周最低:1.34
股本:945.21万
流通股本:900.82万
量比:3.80
换手率:5.99%
股息:- -
股息率:- -
每股收益(TTM):-2.2100
每股收益(LYR):-8.3544
净资产收益率:-119.57%
总资产收益率:-58.44%
市净率:0.44
市盈率(LYR):-0.17

数据加载中...

2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/11

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

重要事件披露

Form 8-K - Current report